Cell and Gene Therapy for Oncology Market, By Therapy Type, By Technology, By Indication, By End User, By Geography

Description

Cell and Gene Therapy for Oncology Market is estimated to be valued at USD 8,641.9 Mn in 2026 and is expected to reach USD 138,425.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 44.7% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 8,641.9 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	44.70%	2033 Value Projection:	USD 138,425.0 Mn

The market for global cell and gene therapy for oncology is among the fastest-growing markets in the field of oncology therapeutics due to the growing number of cancers and the increasing need for personalized and targeted therapeutic solutions. The major firms engaged in this field are striving to develop state-of-the-art treatments such as CAR-T, TCR, and genetically engineered immunotherapy that provide better results than existing therapies.

The technological progress in gene editing, development of viral vectors, and cell engineering technologies is revolutionizing the cancer therapy process. There are several other factors contributing to the market's growth such as increased participation in clinical trials, approvals, and financial investments by biopharmaceutical companies. Moreover, rising use of precision medicine, improvements in production, and strategic partnerships are driving innovation in the cell and gene-based cancer treatment market.

Market Dynamics

The global cell and gene therapy for oncology market is spurred by an increasing burden of cancer across the globe and an increasing demand for oncology treatments that offer greater precision. Increased public awareness about new cancer therapies, coupled with advances made in techniques like CAR-T cell therapy, gene-editing, and viral vectors, is further boosting the growth of the market. Moreover, an increased number of clinical trials and investment in innovative oncology treatments by major players in biopharmaceuticals can be seen.

Some of the factors restricting the growth of the market include the high costs associated with oncology cell and gene therapy, the high costs of production, and stringent regulatory frameworks for the same. Safety issues related to the adverse side effects of such procedures, such as cytokine release syndrome, also present themselves. Nevertheless, there are ample opportunities for growth within the market, owing to the rise of allogenic and off-the-shelf therapies, wider applications for solid tumors, and increased investments in manufacturing facilities.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cell and gene therapy for oncology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study Gilead Sciences, Novartis AG, Bristol Myers Squibb, Johnson & Johnson, Legend Biotech, bluebird bio, CRISPR Therapeutics, Allogene Therapeutics, Iovance Biotherapeutics, and Adaptimmune Therapeutics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global cell and gene therapy for oncology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell and gene therapy for oncology market

Market Segmentation

Therapy Type Insights (Revenue, USD Mn, 2021 - 2033)
- Cell Therapy
- Stem Cell Therapy
- T-Cell Therapy
- Mesenchymal Stem Cell (MSC) Therapy
- Others
- Gene Therapy
- Gene Induced Immunotherapy
- Oncolytic Virotherapy
- Therapy Gene Transfer
Technology Insights (Revenue, USD Mn, 2021 - 2033)
- Cell Therapy Technology
- Autologous
- Allogeneic
- Xenogeneic
- Gene Therapy Technology
- Viral Vector-Based Gene Therapy
- Non-Viral Vector-Based Gene Therapy
Indication Insights (Revenue, USD Mn, 2021 - 2033)
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Leukaemia and Lymphoma
- Others
End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals and Cancer Treatment Centers
- Research and Academic Institutes
- Biotechnology and Pharmaceutical Companies
- Others
Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Gilead Sciences
- Novartis AG
- Bristol Myers Squibb
- Johnson & Johnson
- Legend Biotech
- bluebird bio
- CRISPR Therapeutics
- Allogene Therapeutics
- Iovance Biotherapeutics
- Adaptimmune Therapeutics

Product Code: CMI9477

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Cell and Gene Therapy for Oncology Market, By Therapy Type
- Global Cell and Gene Therapy for Oncology Market, By Technology
- Global Cell and Gene Therapy for Oncology Market, By Indication
- Global Cell and Gene Therapy for Oncology Market, By End User
- Global Cell and Gene Therapy for Oncology Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Key Developments
Industry Trends

4. Global Cell and Gene Therapy for Oncology Market, By Therapy Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Stem Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
T-Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Mesenchymal Stem Cell (MSC) Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Gene Induced Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Oncolytic Virotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Therapy Gene Transfer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Cell and Gene Therapy for Oncology Market, By Technology, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Cell Therapy Technology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Autologous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Allogeneic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Xenogeneic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Gene Therapy Technology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Viral Vector-Based Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Non-Viral Vector-Based Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Cell and Gene Therapy for Oncology Market, By Indication, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Leukaemia and Lymphoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Cell and Gene Therapy for Oncology Market, By End User, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals and Cancer Treatment Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Biotechnology and Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Cell and Gene Therapy for Oncology Market, By Region, 2021 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Gilead Sciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Legend Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
bluebird bio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CRISPR Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Allogene Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Iovance Biotherapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Adaptimmune Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us